These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31544074)

  • 1. Pharmacovigilance of Cutaneous Adverse Drug Reactions among Patients Attending Dermatology Department at a Tertiary Care Hospital.
    Sharma S; Jayakumar D; Palappallil DS
    Indian Dermatol Online J; 2019; 10(5):547-554. PubMed ID: 31544074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India.
    Mittal N; Gupta M; Singla M
    Cutan Ocul Toxicol; 2014 Dec; 33(4):289-93. PubMed ID: 24517496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Study of Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Andhra Pradesh, India.
    Ashifha S; Vijayashree J; Vudayana K; Chintada D; P P; G P; Unnikrishnan P
    Cureus; 2023 Apr; 15(4):e37596. PubMed ID: 37197134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nevirapine: Most Common Cause of Cutaneous Adverse Drug Reactions in an Outpatient Department of a Tertiary Care Hospital.
    Pawar MP; Pore SM; Pradhan SN; Burute SR; Bhoi UY; Ramanand SJ
    J Clin Diagn Res; 2015 Nov; 9(11):FC17-20. PubMed ID: 26672558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacovigilance of the cutaneous drug reactions in outpatients of dermatology department at a tertiary care hospital.
    S D I; M M; N S M; Amutha A; I GJ; Rahman F
    J Clin Diagn Res; 2012 Dec; 6(10):1688-91. PubMed ID: 23373029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Clinical Spectrum of Cutaneous Adverse Drug Reactions in Patients Presenting at a Tertiary Care Hospital in Pakistan.
    Hina A; Masood S; Jamil S; Tabassum S; Jalil P; Ghulam U
    Cureus; 2021 Apr; 13(4):e14568. PubMed ID: 34026384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Cutaneous Adverse Drug Reactions (ADR) Reported at an ADR Monitoring Center of a Tertiary Care Teaching Institute in Central India.
    Chindhalore CA; Gupta AV; Dakhale GN; Srivastava A
    Cureus; 2024 Feb; 16(2):e53706. PubMed ID: 38455795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An observational study of cutaneous adverse drug reactions in a teaching hospital.
    Chopra D; Sharma V; Kapoor R; Dwivedi S
    Int J Clin Pharm; 2015 Dec; 37(6):996-9. PubMed ID: 26238222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspective.
    Nandha R; Gupta A; Hashmi A
    Int J Appl Basic Med Res; 2011 Jan; 1(1):50-3. PubMed ID: 23776774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous adverse drug reaction profile in a tertiary care out patient setting in eastern India.
    Saha A; Das NK; Hazra A; Gharami RC; Chowdhury SN; Datta PK
    Indian J Pharmacol; 2012; 44(6):792-7. PubMed ID: 23248414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective Analysis of Pattern of Cutaneous Adverse Drug Reactions in Tertiary Hospital of Pauri Garhwal.
    Dimri D; Raina RS; Thapliyal S; Thawani V
    J Clin Diagn Res; 2016 May; 10(5):FC01-6. PubMed ID: 27437240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous Adverse Drug Reactions in a Tertiary Care Teaching Hospital in India: An Intensive Monitoring Study.
    Thakkar S; Patel TK; Vahora R; Bhabhor P; Patel R
    Indian J Dermatol; 2017; 62(6):618-625. PubMed ID: 29263536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Profile and Comparison of Causality Assessment Tools in Cutaneous Adverse Drug Reactions.
    Beniwal R; Gupta LK; Khare AK; Mittal A; Mehta S; Balai M
    Indian Dermatol Online J; 2019; 10(1):27-33. PubMed ID: 30775295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous adverse drug reactions in Indian population: A systematic review.
    Patel TK; Thakkar SH; Sharma D
    Indian Dermatol Online J; 2014 Dec; 5(Suppl 2):S76-86. PubMed ID: 25593813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Clinico-Epidemiological Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Centre of Eastern India.
    Sinha S; Kar C; Das S; Dutta A; De A
    Indian J Dermatol; 2024; 69(1):106. PubMed ID: 38572036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence.
    Sharma PK; Misra AK; Gupta A; Singh S; Dhamija P; Pareek P
    Indian J Pharmacol; 2018; 50(5):273-278. PubMed ID: 30636831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric pharmacovigilance in an institute of national importance: Journey has just begun.
    Sharma PK; Misra AK; Gupta N; Khera D; Gupta A; Khera P
    Indian J Pharmacol; 2017; 49(5):390-395. PubMed ID: 29515280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Sensitivities of Skin Prick and Intradermal Tests with Oral Rechallenge Test: A Prospective Interventional Hospital-Based Study.
    Singh SK; Bohara A; Rai T
    Indian J Dermatol; 2021; 66(1):55-59. PubMed ID: 33911294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.